Learn more

MASSACHUSETTS EYE & EAR INFIRM

Overview
  • Total Patents
    254
  • GoodIP Patent Rank
    32,847
About

MASSACHUSETTS EYE & EAR INFIRM has a total of 254 patent applications. Its first patent ever was published in 1986. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are SCHEPENS EYE RES INST, THE GENERAL HOSPITAL CORP DBA MASSACHUSETTS GENERAL HOSPITAL and CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA BIOCUBAFARMA.

Patent filings per year

Chart showing MASSACHUSETTS EYE & EAR INFIRMs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Miller Joan W 36
#2 Gragoudas Evangelos S 28
#3 Azar Dimitri T 26
#4 Edge Albert 25
#5 Merfeld Daniel M 13
#6 Rauch Steven D 11
#7 Epstein David L 10
#8 Adamis Anthony P 10
#9 Renno Reem Z 9
#10 Friend Stephen 9

Latest patents

Publication Filing date Title
WO2016077382A2 Conjunctivitis vaccines
WO2016069906A1 Efficient delivery of therapeutic molecules to cells of the inner ear
WO2016022776A2 Increasing atoh1 life to drive sensorineural hair cell differentiantion
WO2015130944A1 Methods for cross-linking corneal collagen with verteporfin for the treatment of disorders of the eye
WO2015077786A1 Piezoelectric sensors for hearing aids
WO2015054298A1 Methods of preventing or reducing photoreceptor cell death
WO2014150690A1 Vestibular testing
US2016038760A1 Conjunctival diseases
US2014247020A1 Energy extraction
US2014256627A1 Methods of delivering pharmaceutical agents
WO2014106021A1 Treatment of rhinosinusitis with p-glycoprotein inhibitors
WO2013148269A1 Methods and compositions for reducing the proliferation of gram positive bacteria
WO2013126599A1 Meibomian gland dysfunction
US2013122017A1 Osteoprotegerin in neuroprotection
CN104427960A Adaptive visual assistive device
US2014357570A1 Compositions comprising necrosis inhibitors, such as necrostatins, alone or in combination, for promoting axon regeneration and nerve function, thereby treating cns disorders
WO2012177976A2 Auditory stimulus for auditory rehabilitation
US2013046214A1 Mechanical actuator for a vestibular stimulator
WO2012167109A2 Rpgrip1 gene therapy for leber congenital amaurosis
WO2012149573A2 Electronic intubation